Myriad Genetics Inc (NASDAQ:MYGN)

Delayed Data
As of 4:00pm ET
 +0.76 / +2.33%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 31.50, with a high estimate of 45.00 and a low estimate of 18.00. The median estimate represents a -5.43% decrease from the last price of 33.31.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.35%
Growthannually 0.47%


Growthquarterly -0.86%
Growthannually -0.24%
Key to the earnings and sales forecast charts.